Sunshine Biopharma (SBFM)
1.5600 x 23 1.5800 x 2
Post-market by (Cboe BZX)
1.5700 -0.2700 (-14.67%) 04/04/25 [NASDAQ]
1.5600 x 23 1.5800 x 2
Post-market 1.5600 -0.0100 (-0.64%) 19:58 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,687 | 16,292 | 21,826 | 2,045 | 990 |
| Receivables | 3,868 | 2,552 | 1,912 | 8 | 2 |
| Inventories | 11,278 | 5,735 | 3,290 | 106 | 24 |
| Other current assets | 0 | 0 | 0 | 8 | 8 |
| TOTAL | $25,966 | $24,890 | $27,312 | $2,196 | $1,026 |
| Non-Current Assets | |||||
| PPE Net | 546 | 366 | 394 | 7 | 20 |
| Intangibles | 3,020 | 1,444 | 777 | 0 | 0 |
| Other Non-Current Assets | 1,028 | 647 | 760 | 0 | 0 |
| TOTAL | $4,594 | $2,457 | $1,932 | $7 | $20 |
| Total Assets | $30,560 | $27,347 | $29,244 | $2,203 | $1,046 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,839 | 5,133 | 6,435 | 43 | 63 |
| Accrued Expenses | N/A | N/A | N/A | 48 | 24 |
| TOTAL | $6,315 | $5,552 | $6,931 | $91 | $1,051 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,900 | 949 |
| aiOther Non-Current Liabilities | 745 | 539 | 642 | 0 | 0 |
| TOTAL | $745 | $588 | $685 | $1,900 | $949 |
| Total Liabilities | $7,060 | $6,140 | $7,616 | $1,991 | $2,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,708 | 50 | 11 | 4 | 2 |
| Common Shares | 3 | 0 | 23 | 3 | 2 |
| Retained earnings | -69,040 | -63,906 | -59,400 | -32,655 | -20,219 |
| Other shareholders' equity | -830 | 696 | 162 | -23 | -3 |
| TOTAL | $23,501 | $21,207 | $21,628 | $212 | $-955 |
| Total Liabilities And Equity | $30,560 | $27,347 | $29,244 | $2,203 | $1,046 |